MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1

miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer

(2015) Yunhui Hu et al.   BREAST CANCER RESEARCH AND TREATMENT

miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin

(2015) X Zhu et al.   ONCOGENE

The Effects and Molecular Mechanisms of MiR-106a in Multidrug Resistance Reversal in Human Glioma U87/DDP and U251/G Cell Lines

(2015) Qin Wang et al.   PLoS One

miR-186 Regulates Glycolysis through Glut1 During the Formation of Cancer-associated Fibroblasts

(2014) Pan Sun et al.   Asian Pacific Journal of Cancer Prevention

MicroRNAs and their relevance to ABC transporters

(2014) Sierk Haenisch et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches

(2014) Qiong Wu et al.   CANCER LETTERS

miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6

(2014) Xiaolan Zhu et al.   INTERNATIONAL JOURNAL OF CANCER

HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein

(2014) Jianfang Chen et al.   PLoS One

MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells

(2014) Guanghui Cui et al.   TUMOR BIOLOGY

Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosis

(2014) Michael Schnekenburger et al.   Frontiers in Pharmacology

MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2)

(2013) Meng-Tao Ma et al.   CANCER LETTERS

Restoration of chemosensitivity in cancer cells with MDR phenotype by deoxyribozyme, compared with ribozyme

(2013) Ai-Yan Xing et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Regulation of the MDR1 promoter by E2F1 and EAPP

(2013) Peter Andorfer et al.   FEBS LETTERS

miR-186 Downregulation Correlates with Poor Survival in Lung Adenocarcinoma, Where It Interferes with Cell-Cycle Regulation

(2012) J. Cai et al.   CANCER RESEARCH

MDR Gene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines

(2012) Radosław Januchowski et al.   Biomed Research International

Shielding the messenger (RNA): microRNA-based anticancer therapies

(2011) Elena Sotillo et al.   PHARMACOLOGY & THERAPEUTICS

MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells

(2010) Zhimin Li et al.   GYNECOLOGIC ONCOLOGY

Mammalian microRNAs predominantly act to decrease target mRNA levels

(2010) Huili Guo et al.   NATURE

Targeting microRNAs in cancer: rationale, strategies and challenges

(2010) Ramiro Garzon et al.   NATURE REVIEWS DRUG DISCOVERY

Regulation of ABCG2 Expression at the 3' Untranslated Region of Its mRNA through Modulation of Transcript Stability and Protein Translation by a Putative MicroRNA in the S1 Colon Cancer Cell Line

(2008) K. K. W. To et al.   MOLECULAR AND CELLULAR BIOLOGY

Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition

(2008) S.-F. Zhou   XENOBIOTICA